Growth Metrics

Microbot Medical (MBOT) Liabilities and Shareholders Equity (2016)

Microbot Medical's Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $2.1 million for Q3 2016.

  • For the quarter ending Q3 2016, Liabilities and Shareholders Equity fell 92.44% year-over-year to $2.1 million, compared with a TTM value of $25.9 million through Dec 2016, down 70.29%, and an annual FY2015 reading of $529000.0, changed N/A over the prior year.
  • Liabilities and Shareholders Equity for Q3 2016 was $2.1 million at Microbot Medical, down from $6.3 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $42.8 million in Q3 2014, with the low at $529000.0 in Q4 2015.
  • Average Liabilities and Shareholders Equity over 5 years is $25.4 million, with a median of $28.4 million recorded in 2015.
  • Year-over-year, Liabilities and Shareholders Equity surged 100.86% in 2013 and then crashed 98.37% in 2015.
  • Tracing MBOT's Liabilities and Shareholders Equity over 5 years: stood at $30.2 million in 2012, then skyrocketed by 37.74% to $41.6 million in 2013, then decreased by 21.97% to $32.4 million in 2014, then crashed by 98.37% to $529000.0 in 2015, then surged by 305.36% to $2.1 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Liabilities and Shareholders Equity are $2.1 million (Q3 2016), $6.3 million (Q2 2016), and $17.4 million (Q1 2016).